Clinical trial
Efficacy and Safety of Rimonabant as an Aid to Maintenance of Smoking Cessation
NCT00459173 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00459173 |
|---|---|
| Title | Efficacy and Safety of Rimonabant as an Aid to Maintenance of Smoking Cessation |
| Official title | Comparison of the Efficacy and Safety of 2 Oral Doses of Rimonabant, 5 mg/Day or 20 mg/Day, Versus Placebo, as an Aid to Maintenance of Smoking Cessation (1-Year Treatment, 1-Year Follow-up) |
| Acronym | STRATUS-WW |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Maintenance of Smoking Cessation |
| Intervention type | Drug |
| Interventions | rimonabant (SR141716) |
| Enrollment | 4,850 |
| Start date | Nov 1, 2002 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Apr 11, 2007 |
| Last update posted | Apr 7, 2009 |
| Countries | Australia, Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: